CRISPR-Cas9 Mediated Epigenetic Reprogramming of Cardiac Fibroblasts As a Therapeutic Strategy for Post-Infarction Myocardial Remodeling. ISCSITR-IJMSRD 2024, 5 (2), 1-9.